Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.
Saved in:
| Title: | Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy. |
|---|---|
| Authors: | Cheng, Heather H.1,2, Soleau, Colleen1, Yu, Evan Y.1,2,3 evanyu@uw.edu |
| Source: | Journal of Hematology & Oncology. 2015, Vol. 8 Issue 1, p1-5. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
